To test this, the effects of 60 μM Sp-8-Br-cAMPS on breast cancer cell migration and proliferation were assessed following POPDC1 knockdown in MCF7, MDA231 and SKBR3 cells (Figure 7). Here, POPDC1 is linked to breast carcinoma.